deCODE is continuing its research on both phenotypes to identify and analyze the roles of these genes, with the aim of finding
novel diagnostic markers as well as drug targets that can be used to combat asthma and allergies by going to the underlying causes of both conditions.
Recent progress in biochemistry and pathophysiology has enabled search for
novel diagnostic markers and therapeutic targets to improve cardiovascular outcomes globally.
Not exact matches
A detailed understanding of how TSPO binds to such
markers opens up
novel paths for
diagnostic imaging and could constitute an important step along the way to early detection of such diseases and inflammations.
Floryne Buishand, 30, from the Netherlands, is a postdoctoral researcher at the National Cancer Institute / NIH, Bethesda, USA, studies genomic changes associated with endocrine cancers with the ultimate goal of identifying
novel diagnostic and prognostic
markers, as well as
novel therapeutic targets.
My short term goals for my postdoc are to identify
novel diagnostic and prognostic
markers, as well as
novel therapeutic targets, leading to several high impact first authored publications.